Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease
THURSDAY, April 11, 2024 -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2024 Category: Pharmaceuticals Source Type: news
Lupin gets USFDA nod to market generic medication
Lupin has gained approval from the USFDA to market generic Valbenazine Capsules, used to treat tardive dyskinesia. This medication is equivalent to Neurocrine Biosciences, Inc's Ingrezza Capsules. Lupin is among the first applicants for this generic drug, entitling them to 180 days of shared exclusivity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Tardive Dyskinesia Impact Scale Captures Relevant Info About Condition
FRIDAY, Jan. 19, 2024 -- The Tardive Dyskinesia Impact Scale (TDIS) patient-reported outcome measure captures information about the impact of TD, according to a study published online Jan. 4 in the Journal of Patient-Reported Outcomes.
Robert H.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2024 Category: Pharmaceuticals Source Type: news
Tardive Dyskinesia Impacts Patients and Caregivers
FRIDAY, Dec. 8, 2023 -- Tardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.
Rakesh Jain, M.D., M.P.H., from the Texas... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 8, 2023 Category: Pharmaceuticals Source Type: news
Phenytoin-induced Dyskinesia Phenytoin-induced Dyskinesia
Several antiepileptic drugs have been linked to involuntary movements. This case highlights the need to be aware of phenytoin-induced dyskinesia, which is reversible upon discontinuation of the drug.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Dyskinesia due to mexiletine overdose: a rare presentation - Öztürk Z, Aydın O, Bodur, Yaradılmış RM, Çelik HA, Tuygun N.
BACKGROUND: Mexiletine, a class IB antiarrhythmic, is a structural analog of lidocaine. Our knowledge of mexiletine overdose is based on lidocaine overdose reports. Only a few cases of mexiletine overdose have been reported, including fatal overdoses. Mexi... (Source: SafetyLit)
Source: SafetyLit - September 6, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Tardive Dyskinesia Has Considerable Impact on Multiple Domains
TUESDAY, Aug. 22, 2023 -- Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry.
Rakesh Jain, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 22, 2023 Category: Pharmaceuticals Source Type: news
One-Hour Training Improves Documentation to Diagnose, Treat Tardive Dyskinesia
TUESDAY, July 18, 2023 -- An annual one-hour Abnormal Involuntary Movement Score (AIMS) training session improves documentation to recognize and treat tardive dyskinesia in the psychiatry outpatient clinic, according to a study recently published in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 18, 2023 Category: Pharmaceuticals Source Type: news
Sex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia
FRIDAY, May 19, 2023 -- For schizophrenia patients with tardive dyskinesia (TD), there may be sex differences in cognitive impairment, with a protective effect suggested by female gender, according to a study published in the May issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2023 Category: Pharmaceuticals Source Type: news
Patient-Rated Tardive Dyskinesia Linked to QoL, Social Functioning
WEDNESDAY, April 19, 2023 -- For antipsychotic-treated outpatients, patient-rated severity and impact of possible tardive dyskinesia (TD) is associated with health-related quality of life and social functioning, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2023 Category: Pharmaceuticals Source Type: news
Concussion-induced oromandibular dyskinesia - Zhang B, Settineri JP, Chajet A, Muthukanagaraj P.
We present a rare case of concussion-induced chronic oromandibular dyskinesia. The patient is a 51-year-old Caucasian male with complex medical history (including a history of multiple concussions) who presented to the emergency department for suicidal and... (Source: SafetyLit)
Source: SafetyLit - April 17, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
NeuroRPM obtains FDA 510(k) for Parkinson's monitoring on Apple Watch
The AI-powered app allows for remote monitoring of common Parkinson ' s disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch. (Source: mobihealthnews)
Source: mobihealthnews - March 24, 2023 Category: Information Technology Source Type: news
Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson's Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson's
Focused ultrasound ablation significantly reduced tremors and improved mobility for patients with PD; the benefits persisted up to a year after treatment.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 3, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Unilateral Pallidal Ultrasound Ablation Beneficial in Parkinson Disease
THURSDAY, March 2, 2023 -- For patients with Parkinson disease, unilateral pallidal ultrasound ablation yields greater improved motor function or reduced dyskinesia, according to a study published in the Feb. 23 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2023 Category: Pharmaceuticals Source Type: news
Austedo XR OK'd; USPSTF's Perinatal Depression Plan; Cannabis Use Disorder Rising
(MedPage Today) -- The FDA approved a once-daily, extended-release version of deutetrabenazine (Austedo XR) in 6, 12, and 24 mg tablet strengths for adults with tardive dyskinesia and chorea associated with Huntington's disease, Teva Pharmaceuticals... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 1, 2023 Category: Psychiatry Source Type: news
